$NNOX

Exclusive distribution agreement marks Nanox’s entry into the Peruvian market

Nanox Imaging (NASDAQ: NNOX) said it signed an exclusive distribution agreement with Top Med SAC for Peru to deploy the Nanox.ARC system and related services. Top Med will handle regulatory approvals, marketing, installation, maintenance, training and support. The deal is a capex model with an initial expected deployment of six systems, subject to permits.

Original reporting
Published Jun 2, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 2, 2026, 1:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Exclusive distribution agreement marks Nanox’s entry into the Peruvian market — source image
Decision brief

The 30-second read

$NNOXBullishMed
01

Why it matters

The key tradable variable is whether the six-system initial deployment progresses from pilot to permitted installations and whether the capex model yields repeatable commercial traction.

02

Market read

A specific international commercialization contract (exclusive distributor, initial six systems) is a positive catalyst, but near-term financial impact hinges on permits and milestone completion.

03

What to watch

Because Top Med is newly established and deployment is milestone/permitting dependent, execution risk (regulatory timelines, installation capacity, service quality) could dominate the stock reaction.

Relevance 8/10Novelty 7/10Timing: today’s deal announcement; watch for follow-through on permits/milestones over coming weeks

Background

Nanox is marketing its Nanox.ARC digital tomosynthesis system (FDA-cleared, CE marked) alongside platform services; this is positioned as an exclusive distributor entry into Peru.

Company-level read

Ticker impact

$NNOXBullishMedium confidence
Context

Nanox signed an exclusive Peru distribution agreement for Nanox.ARC, targeting an initial six-system capex deployment subject to permits and milestones.

Expected impact

Mild-to-moderate positive bias for NNOX as investors price incremental commercialization progress; magnitude likely capped until permits/milestones are confirmed.

Evidence & confidence

The deal is specific (exclusive distributor, six systems, capex model) and FDA/CE-cleared product reduces technical risk, but the article conditions deployment on permits and does not quantify financial terms or timing beyond an initial pilot/rollout framework.

Market effects

Supports the broader theme of AI-enabled/low-cost imaging systems expanding into underserved geographies via local distribution partners.

Highlights Peru as a target market for diagnostic imaging capacity expansion; may increase attention on Latin America healthcare imaging procurement.

Reinforces Nanox’s international commercialization cadence and distributor-led scaling model beyond its home markets.

Counterpoint

The agreement may not translate into near-term revenue if permits slip or the pilot fails to convert into broader rollout.

Key entities

  • Nanox Imaging Ltd.

    NASDAQ-listed medical imaging technology company announcing an exclusive Peru distribution agreement for Nanox.ARC.

  • Top Med SAC

    Exclusive distributor in Peru responsible for regulatory approvals, marketing, installation, maintenance, training, and support.

  • TopRad LLC

    U.S.-based teleradiology provider with common ownership ties to Top Med; not a party to the distribution agreement.

Related articles

$NNOXMed

Nano X Imaging Ltd (NNOX) (Q2 2026) Earnings Call Highlights: Re

Nano X Imaging Ltd (NNOX) reported a 37% year-over-year revenue increase in Q2 2026, driven by growth in teleradiology services and new partnerships. The company also announced operational streamlining and cost reductions. However, NNOX recorded a $40.7 million impairment charge, a significant decrease in cash position, and a widened net loss of $55.5 million. Management expects revenue traction in the coming months and potential market expansion due to new reimbursement codes.

$NNOXHigh

Nano-X Imaging Ltd. (NNOX): Financial results for Q2 2026

Nano-X Imaging Ltd. (NNOX) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates Management to host conference call and webcast on Wednesday, September 9, 2026 at 8:30 AM ET PETACH TIKVA, Israel — September 9, 2026 — NANO-X IMAGING LTD (NASDAQ: NNOX) (“ Nanox ” or

$NNOXMed

NANO-X IMAGING LTD: Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom

Nanox Imaging Ltd (NASDAQ: NNOX) said its subsidiary Nanox AI entered an exclusive UK sales reseller agreement with Vertec Scientific for commercialization of Nanox.AI bone solution (HealthOST). The initial three-year term requires Vertec to meet minimum annual license commitments. HealthOST is FDA-cleared and UKCA/CE-marked and was recommended by NICE in Nov 2025 for NHS use.

$NTAPMed

NTAP Stock Hits Record High: NetApp Expands Strategic Partnerships With SAP, Oracle, and Supermicro To Drive Cloud Infrastructure

NetApp (NTAP) shares reached a record high after announcing strategic partnerships with SAP, Oracle (ORCL), and Supermicro (SMCI) to enhance cloud infrastructure and AI capabilities. NTAP stock rose 2.5% on Tuesday, marking its fifth consecutive day of gains. The company also introduced technical advancements and expanded data sovereignty controls within its NetApp Keystone subscription model.

$CSIQHigh

Why is Canadian Solar stock surging 10% today?

Canadian Solar (CSIQ) stock rose 10.3% to $11.50 after Phase IV Research noted potential for a rebound due to improving margins. The rally was driven by short covering and institutional investments, with the company's Indiana facility expected to boost margins. The broader market had little impact, and the next earnings report is scheduled for mid-November.